Live Price
Live Volume
Chart Volume 0
Volume 0
5 secLyell Immunopharma Market Segments
Premarket
*No Trades in Segment
Overnight
*No Trades in Segment
After Hours Yesterday
+0.31(+2.01%)
| Open | $15.43 |
|---|---|
| Close | $15.74 |
| Low | $14.74 |
| Low Change | -0.69 (-4.47%) |
| High | $16.28 |
| High Change | +0.85 (+5.52%) |
| Range | $1.54 |
| Volume | 29.152K |
| Dollar Volume | $458.85K |
Regular Trading Hours Yesterday
+3.34(+27.63%)
| Open | $12.09 |
|---|---|
| Close | $15.43 |
| Low | $12.09 |
| Low Change | 0.00 (0.00%) |
| High | $16.73 |
| High Change | +4.64 (+38.38%) |
| Range | $4.64 |
| Volume | 1.051M |
| Dollar Volume | $16.22M |
Premarket Yesterday
+0.65(+5.70%)
| Open | $11.32 |
|---|---|
| Close | $11.97 |
| Low | $11.23 |
| Low Change | -0.09 (-0.83%) |
| High | $12.05 |
| High Change | +0.73 (+6.41%) |
| Range | $0.82 |
| Volume | 7.064K |
| Dollar Volume | $84.56K |
Lyell Immunopharma News
Lyell Immunopharma Top Trades
We are still processing the top long and short trades for today. Please refresh the page in 10 minutes or sign up for Finsuba Premium for real time trade insights.
Lyell Immunopharma Moving Averages
| 5 Day Moving Average (SMA5) | $11.89 |
|---|---|
| 10 Day Moving Average (SMA10) | $10.86 |
| 20 Day Moving Average (SMA20) | $9.71 |
| 50 Day Moving Average (SMA50) | $10.86 |
| 100 Day Moving Average (SMA100) | $12.31 |
| 200 Day Moving Average (SMA200) | $16.70 |
Lyell Immunopharma Statistics
| Average Volume (30 Days) | 133.44K |
|---|---|
| P/E Ratio (Current) | -.86 |
| EPS (Current) | -$10.14 |
| Dividend Yield | 0.00% |
| Free Cash Flow | -$133.97M |
| Cash Ratio | 1.83 |
| Current Ratio | 5.36 |
| Quick Ratio | 5.36 |
| Debt to Equity | 0.00 |
| Enterprise Value | $140.45M |
| EV to EBITDA | -0.77 |
| EV to Sales | 5202.03 |
| Price to Book | 0.91 |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | 7905.18 |
| Return on Assets | -0.80% |
| Return on Equity | -1.06% |
Lyell Immunopharma Stock Splits
There has been 1 stock split for Lyell Immunopharma (LYEL). The reverse stock split occured on June 2, 2025 and reduced the outstanding shares at a ratio of 20:1.
| Date | Type | Ratio |
|---|---|---|
| Jun 2, 2025 | Reverse | 20:1 |
Lyell Immunopharma Dividends
There have been no dividends for Lyell Immunopharma (LYEL).